The Blackstone president and his wife are funding a new Penn institute that uses AI and biomarkers to intercept hereditary cancers at their earliest stages.
A comprehensive review recently published in Current Molecular Pharmacology (2026, Volume 19, Pages 85–96) examines the ...
What she does not know is that the hospital will run her clinical notes, imaging reports, and other available health data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results